{"id":"https://openalex.org/W1998378967","doi":"https://doi.org/10.1097/00001813-200209000-00009","title":"Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer","display_name":"Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer","publication_year":2002,"publication_date":"2002-09-01","ids":{"openalex":"https://openalex.org/W1998378967","doi":"https://doi.org/10.1097/00001813-200209000-00009","mag":"1998378967","pmid":"https://pubmed.ncbi.nlm.nih.gov/12394269"},"language":"en","primary_location":{"id":"doi:10.1097/00001813-200209000-00009","doi":"https://doi.org/10.1097/00001813-200209000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-200209000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039073496","display_name":"Miquel Nogu\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115578","display_name":"Corporaci\u00f3 Sanit\u00e0ria Parc Taul\u00ed","ror":"https://ror.org/02pg81z63","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210115578"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Miquel Nogu\u00e9","raw_affiliation_strings":["Consorci Hospitalari del Parc Tauli, 08208 Sabadell, Spain. mnogue@cspt.es","Consorci Hospitalari del Parc Tauli, 08208 Sabadell, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consorci Hospitalari del Parc Tauli, 08208 Sabadell, Spain. mnogue@cspt.es","institution_ids":["https://openalex.org/I4210115578"]},{"raw_affiliation_string":"Consorci Hospitalari del Parc Tauli, 08208 Sabadell, Spain","institution_ids":["https://openalex.org/I4210115578"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lluis Cirera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096566","display_name":"University Hospital M\u00fatua de Terrassa","ror":"https://ror.org/011335j04","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096566","https://openalex.org/I4210130102"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Lluis Cirera","raw_affiliation_strings":["Hospital Mutua de Terrassa, 08221 Terrassa, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Mutua de Terrassa, 08221 Terrassa, Spain","institution_ids":["https://openalex.org/I4210096566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079628452","display_name":"\u00c0ngels Arcusa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098336","display_name":"Consorci Sanitari de Terrassa","ror":"https://ror.org/01239b432","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210098336"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Angels Arcusa","raw_affiliation_strings":["Consorci Sanitari de Terrassa, 08227 Terrassa, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consorci Sanitari de Terrassa, 08227 Terrassa, Spain","institution_ids":["https://openalex.org/I4210098336"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058891467","display_name":"Eduard Batiste-Alentorn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eduard Batiste-Alentorn","raw_affiliation_strings":["Hospital General de Vic, 08500 Vic, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital General de Vic, 08500 Vic, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111611513","display_name":"Anna Balil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802050926","display_name":"Hospital Universitari Arnau de Vilanova","ror":"https://ror.org/01p3tpn79","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050926","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Anna Balil","raw_affiliation_strings":["Hospital Arnau de Vilanova de Lleida, 25198 Lleida, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Arnau de Vilanova de Lleida, 25198 Lleida, Spain","institution_ids":["https://openalex.org/I2802050926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011627931","display_name":"Albert Font Pous","orcid":"https://orcid.org/0000-0003-3908-1111","observed_orcids":["https://orcid.org/0000-0003-3908-1111"]},"institutions":[{"id":"https://openalex.org/I4210153460","display_name":"Hospital Universitari Germans Trias i Pujol","ror":"https://ror.org/04wxdxa47","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210153292","https://openalex.org/I4210153460"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Albert Font","raw_affiliation_strings":["Hospital Germans Trias i Pujol, 08915 Badalona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Germans Trias i Pujol, 08915 Badalona, Spain","institution_ids":["https://openalex.org/I4210153460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044557306","display_name":"Jos\u00e9 Luis Perez\u2010Gracia","orcid":"https://orcid.org/0000-0003-4941-9075","observed_orcids":["https://orcid.org/0000-0003-4941-9075"]},"institutions":[{"id":"https://openalex.org/I4210128228","display_name":"Eli Lilly (Spain)","ror":"https://ror.org/033911096","country_code":"ES","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210128228"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose Luis Perez-Gracia","raw_affiliation_strings":["Clinical Research Department, Eli Lilly & Co, 28108 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department, Eli Lilly & Co, 28108 Madrid, Spain","institution_ids":["https://openalex.org/I4210128228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039927103","display_name":"Eva Carrasco","orcid":"https://orcid.org/0000-0002-2771-7197","observed_orcids":["https://orcid.org/0000-0002-2771-7197"]},"institutions":[{"id":"https://openalex.org/I4210128228","display_name":"Eli Lilly (Spain)","ror":"https://ror.org/033911096","country_code":"ES","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210128228"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eva Maria Carrasco","raw_affiliation_strings":["Clinical Research Department, Eli Lilly & Co, 28108 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department, Eli Lilly & Co, 28108 Madrid, Spain","institution_ids":["https://openalex.org/I4210128228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029872518","display_name":"Ignasi Tusquets","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ignasi Tusquets","raw_affiliation_strings":["Hospital del Mar, 08003 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital del Mar, 08003 Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5039073496"],"corresponding_institution_ids":["https://openalex.org/I4210115578"],"apc_list":null,"apc_paid":null,"fwci":1.6915,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.83092653,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"13","issue":"8","first_page":"839","last_page":"845"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9419999718666077},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/advanced-epithelial-ovarian-cancer","display_name":"advanced epithelial ovarian cancer","score":0.9300000071525574},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.9129999876022339},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8040000200271606},{"id":"https://openalex.org/keywords/chemotherapy-naive-patients","display_name":"chemotherapy-naive patients","score":0.7490000128746033},{"id":"https://openalex.org/keywords/tumor-response-rate","display_name":"tumor response rate","score":0.6890000104904175},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9390000104904175},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9789999723434448},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.8999999761581421},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8859999775886536},{"id":"https://openalex.org/keywords/nausea-and-vomiting","display_name":"nausea and vomiting","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9333840608596802},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7304872274398804},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6713232398033142},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.665940523147583},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5949601531028748},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5423290729522705},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5269539952278137},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5256948471069336},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5008840560913086},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4763255715370178},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4523417353630066},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4297693967819214},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39220747351646423}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009375","descriptor_name":"Neoplasms, Glandular and Epithelial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001813-200209000-00009","doi":"https://doi.org/10.1097/00001813-200209000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-200209000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:12394269","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12394269","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W6349928","https://openalex.org/W24553618","https://openalex.org/W1848316250","https://openalex.org/W1863225814","https://openalex.org/W2052846363","https://openalex.org/W2097105130","https://openalex.org/W2101562875","https://openalex.org/W2119148287","https://openalex.org/W2129678716","https://openalex.org/W2139379623","https://openalex.org/W2151037883","https://openalex.org/W2154737435","https://openalex.org/W2272680342","https://openalex.org/W2328421677","https://openalex.org/W2330814896","https://openalex.org/W4248998533","https://openalex.org/W4255483444"],"related_works":["https://openalex.org/W1981494434","https://openalex.org/W1971500783","https://openalex.org/W2087292647","https://openalex.org/W2089952793","https://openalex.org/W2110020593","https://openalex.org/W2325101513","https://openalex.org/W2355238142","https://openalex.org/W2003476023","https://openalex.org/W2151037883","https://openalex.org/W7132584354"],"abstract_inverted_index":{"This":[0],"phase":[1],"II":[2],"study":[3],"evaluated":[4],"the":[5,67,113,152,190],"activity":[6],"of":[7,16,59,93,181,192],"gemcitabine":[8,34,171,193],"(Gemzar)":[9],"plus":[10,172],"cisplatin":[11,43,173],"(Platinol)":[12],"as":[13,178],"first-line":[14,179,195],"treatment":[15,180,196],"advanced":[17,25,182],"epithelial":[18,30,183],"ovarian":[19,31,184],"cancer.":[20,185],"Forty-two":[21],"chemonaive":[22],"patients":[23,69,104],"with":[24,189],"(stage":[26],"III":[27],"and":[28,40,42,79,89,112,144,146,176],"IV)":[29],"cancer":[32],"received":[33],"1,250":[35],"mg/m(2)":[36,45],"on":[37,46],"days":[38],"1":[39],"8":[41],"100":[44],"day":[47],"1,":[48],"every":[49],"3":[50],"weeks,":[51],"up":[52],"to":[53,164,194],"eight":[54],"cycles.":[55],"The":[56,125],"median":[57,114],"number":[58],"cycles":[60],"completed":[61],"was":[62,105,118,127,157],"5":[63],"(range":[64],"2-8).":[65],"Of":[66],"41":[68],"evaluable":[70],"for":[71,85,101],"tumor":[72],"response,":[73,84],"20":[74],"had":[75,81],"a":[76,82],"partial":[77],"response":[78,91],"nine":[80],"complete":[83],"an":[86],"overall":[87,99],"clinical":[88,187],"pathologic":[90],"rate":[92],"70.7%":[94],"(95%":[95,108,121],"CI":[96,109,122],"56.8-84.6%).":[97],"Median":[98],"survival":[100,116],"all":[102],"42":[103],"23.4":[106],"months":[107,120],"15.9-29.9":[110],"months)":[111],"progression-free":[115],"time":[117],"10.4":[119],"9.4-13.5":[123],"months).":[124],"combination":[126],"generally":[128],"manageable.":[129],"Hematologic":[130],"toxicity":[131],"(grade":[132,148],"3/4":[133,137,141],"neutropenia:":[134],"31.0/21.4%;":[135],"grade":[136,140],"thrombocytopenia:":[138],"9.5/4.8%;":[139],"anemia:":[142],"11.9/0%)":[143],"nausea":[145],"vomiting":[147],"3/4:":[149],"35.7/31.0%)":[150],"were":[151],"most":[153],"common":[154],"toxicities.":[155],"There":[156],"one":[158],"toxic":[159],"death":[160],"(septic":[161],"shock":[162],"due":[163],"hematologic":[165],"toxicity-induced":[166],"infection).":[167],"We":[168],"conclude":[169],"that":[170],"is":[174],"active":[175],"feasible":[177],"Further":[186],"trials":[188],"addition":[191],"appear":[197],"warranted.":[198]},"counts_by_year":[{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}